Jade Biosciences, Inc. - COM (AVTE)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / COM
Symbol
AVTE
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-24,414
Value change
-$65,395
Avg sell value change
-0%
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Jade Biosciences, Inc. - COM (AVTE) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of Jade Biosciences, Inc. - COM (AVTE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0 $0 -$65,395 0
2025 Q2 24,414 $65,395 -$79,443,835 259.49% 2
2025 Q1 31,698,351 $79,562,623 +$3,810,131 251% 80
2024 Q4 30,167,836 $79,943,765 +$6,829,223 265% 78
2024 Q3 27,643,944 $57,772,365 +$1,542,783 209% 72
2024 Q2 27,181,632 $45,121,583 -$189,379,190 166% 79
2024 Q1 28,456,703 $841,465,274 +$12,906,968 2,957% 80
2023 Q4 28,185,162 $637,829,902 -$447,674 2,263% 64
2023 Q3 28,465,427 $386,275,633 -$1,301,769 1,357% 58
2023 Q2 28,473,066 $488,311,378 +$39,095,352 1,715% 60
2023 Q1 25,984,813 $524,111,604 -$46,643,480 2,017% 65
2022 Q4 27,403,700 $802,925,527 +$17,762,863 2,930% 68
2022 Q3 26,982,564 $447,365,690 +$20,246,652 1,657.99% 53
2022 Q2 25,769,304 $402,774,000 -$2,773,815 1,562.99% 47
2022 Q1 25,927,935 $475,262,000 +$8,646,401 1,833.01% 44
2021 Q4 25,569,932 $301,454,000 -$15,263,444 1,178.99% 46
2021 Q3 21,654,813 $452,572,000 +$35,117,470 2,097.97% 41
2021 Q2 19,965,251 $454,425,000 +$454,425,000 2,283% 17